• Exchange: -
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Cardiovascular Devices

Theragenics Corp

THX:GR

Ticker Delisted

Snapshot for Theragenics Corp (THX)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for THX

No chart data available.
  • THX:GR 1.563
  • 1M
  • 1Y
0.000
Interactive THX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THX

Current P/E Ratio (ttm) -
Estimated P/E(12/2012) 19.1311
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2012) 0.1100
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THX

No data available

Company Profile & Key Executives for THX

Theragenics Corporation produces and sells implantable radiation devices used in the treatment of cancer. The Company produces and sells TheraSeed, a device based on the radioactive isotope palladium 103. Theragenics' product is used primarily in the treatment of early stage prostate cancer.

Francis J TaralloCFO/TreasurerC Russell SmallExecutive Vice President
Janet ZemanVP:Government Affairs
More Company Profile & Key Executives for THX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil